Official Statements & Press Releases

The Clinical TMS Society recommends the following coverage for Transcranial Magnetic Stimulation for Smoking Cessation COVERAGE INDICATIONS, LIMITATIONS, AND/OR M

The Clinical TMS Society has elected the members who will serve as the 2023-2024 Officers and Board of Directors: 

Updated Theta Burst Statement*

This clarification statement on different types of TMS was produced by the Clinical Standards Committee and supported by the CTMSS Board of Directors.

Stanford Accelerated Intelligent Neuromodulation Therapy (SAINT), a novel approach to providing Transcranial Magnetic Stimulation (TMS) for treatment resistant depression (TRD), has generated consi

FOR IMMEDIATE RELEASE:  Ashleigh Servadio, MSC Executive Director Clinical TMS Society (845) 392.3238 phone (559) 227.1463 fax

FOR IMMEDIATE RELEASE:

The Clinical TMS Society recommends the following coverage for Transcranial Magnetic Stimulation for Major Depressive Disorder COVERAGE INDICATIONS, LIMITATIONS,

FOR IMMEDIATE RELEASE: